- Home
- NVCT vs FNWD Comparison
NVCT vs FNWD Comparison
Compare NVCT & FNWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVCT | FNWD |
|---|---|---|
| Founded | 2020 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 171.9M | 143.6M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | NVCT | FNWD |
|---|---|---|
| Price | $7.53 | $38.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $15.33 | ★ $34.00 |
| AVG Volume (30 Days) | ★ 91.2K | 42.0K |
| Earning Date | 11-04-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 1.25% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.91 |
| Revenue | N/A | ★ $66,563,999.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $8.03 |
| P/E Ratio | ★ N/A | $20.17 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.44 | $26.12 |
| 52 Week High | $11.52 | $39.99 |
Technical Indicators
Market Signals| Indicator | NVCT | FNWD |
|---|---|---|
| Relative Strength Index (RSI) | 72.98 | 66.58 |
| Support Level | $6.47 | $36.37 |
| Resistance Level | $6.84 | $39.99 |
| Average True Range (ATR) | 0.39 | 1.36 |
| MACD | 0.16 | -0.04 |
| Stochastic Oscillator | 95.77 | 76.14 |
Price Performance
Historical ComparisonAbout NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About FNWD Finward Bancorp
Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.